High spending on prescription drugs with both orphan and non-orphan indications suggest potential misuse of Orphan Drug Act designations.
For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans.
JC Scott talks with Julie Goon, Senior Vice President of Public Affairs for Anthem, Inc., and Tim Dube, PCMA’s Vice President of Regulatory Affairs. Together, they discuss good versus bad transparency, how transparency has evolved in healthcare, how it can empower the consumer to have more control over the prices they pay through evolved technology, and which transparency rules decrease prescription drug prices, and which rules actually increase prices.
For America’s pharmacy benefit managers, PBMs, our mission is simple: increase affordable access to prescription drugs for everyone. We believe care should be patient-focused, equitable, and affordable.
PCMA believes that organizational and employee success require a diverse, equitable, and inclusive workforce and a culture that embraces and encourages different perspectives.
PCMA has signed on to the CEO Action for Diversity & Inclusion™ pledge. Read more here.
PCMA released a series of videos showcasing the value PBMs provide employers.
PBMs have distinct business processes that differentiate them in the market, but PBMs also adhere to stringent accreditation standards, the terms of negotiated contracts, and legal requirements.
Learn MoreJanuary 6, 2022
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and...
Keep ReadingDecember 15, 2021
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is...
Keep ReadingJanuary 24, 2022
CDC researchers who analyzed data from 259 hospitals and 383 emergency departments from late August through early January found a...
Keep ReadingJanuary 24, 2022
Pfizer CEO Albert Bourla said it would be better to have a COVID-19 vaccine administered once a year instead of...
Keep Reading
